Charcot-marie-tooth disease in Cyprus: Epidemiological, clinical and genetic characteristics

Neuroepidemiology

Volumn 35, Issue 3, 2010, Pages 171-177

  Nicolaou, Paschalis ^a   Zamba Papanicolaou, Eleni ^a   Koutsou, Pantelitsa ^a   Kleopa, Kleopas A ^a   Georghiou, Anthi ^a   Hadjigeorgiou, Georgios ^b   Papadimitriou, Alexandros ^b   Kyriakides, Theodoros ^a   Christodoulou, Kyproula ^a  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Charcot Marie Tooth disease; Genetic characteristics; Neuropathy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CYPRUS; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUROPHYSIOLOGY; ONSET AGE; POPULATION;

ADULT; AGE OF ONSET; CHARCOT-MARIE-TOOTH DISEASE; CHROMOSOME DUPLICATION; CYPRUS; FEMALE; GENE FREQUENCY; GENETICS, POPULATION; HUMANS; MALE; MYELIN PROTEINS; PEDIGREE; POINT MUTATION; PREVALENCE;

EID: 77953676494     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314351     Document Type: Article

References (37)

1. Barisic N, Claeys KG, Sirotković-Skerlev M, Löfgren A, Nelis E, de Jonghe P, Timmerman V: Charcot-Marie-Tooth disease: a clinicogenetic confrontation. Ann Hum Genet 2008; 72: 416-441.
2. Harding AE, Thomas PK: Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet 1980; 17: 329-336.
3. Berger P, Young P, Suter U: Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics 2002; 4: 1-15.
4. Bird TD: Hereditary motor-sensory neuropathies: Charcot-Marie-Tooth syndrome. Neurol Clin 1989; 7: 9-23.
5. Mastaglia FL, Nowak KJ, Stell R, Phillips BA, Edmondston JE, Dorosz SM, Wilton SD, Hallmayer J, Kakulas BA, Laing NG: Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 1999; 67: 174-179.
6. Dyck PJ, Lambert EH: Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. 1. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 1968; 18: 603-618.
7. Fischbeck KH, ar-Rushdi N, Pericak-Vance M, Rozear M, Roses AD, Fryns JP: X-linked neuropathy: gene localization with DNA probes. Ann Neurol 1986; 20: 527-532.
8. Harding AE, Thomas PK: Autosomal recessive forms of hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 1980; 43: 669-678.
9. Barisic I, Tokic V, Loane M, Bianchi F, Calzolari E, Garne E, Wellesley D, Dolk H: Descriptive epidemiology of Cornelia de Lange syndrome in Europe. Am J Med Genet A 2008; 146A:51-59.
10. Szigeti K, Lupski JR: Charcot-Marie-Tooth disease. Eur J Hum Genet 2009; 17: 703-710.
11. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-517.
12. Stronach EA, Clark C, Bell C, Löfgren A, McKay NG, Timmerman V, van Broeckhoven C, Haites NE: Novel PCR-based diagnostic tools for Charcot-Marie-Tooth type 1A and hereditary neuropathy with liability to pressure palsies. J Peripher Nerv Syst 1999; 4: 117-122.
13. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30:e57.
14. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo- Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI: DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991; 66: 219-232.
15. Kleopa KA, Georgiou DM, Nicolaou P, Koutsou P, Papathanasiou E, Kyriakides T, Christodoulou K: A novel PMP22 mutation Ser22Phe in a family with hereditary neuropathy with liability to pressure palsies and CMT1A phenotypes. Neurogenetics 2004; 5: 171-175.
16. Hayasaka K, Himoro M, Sato W, Takada G, Uyemura K, Shimizu N, Bird TD, Conneally PM, Chance PF: Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet 1993; 5: 31-34. (Pubitemid 23261514)
17. Kleopa KA, Zamba-Papanicolaou E, Alevra X, Nicolaou P, Georgiou DM, Hadjisavvas A, Kyriakides T, Christodoulou K: Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X. Neurology 2006; 66: 396-402.
18. Nicholson GA, Yeung L, Corbett A: Efficient neurophysiologic selection of X-linked Charcot-Marie-Tooth families: ten novel mutations. Neurology 1998; 51: 1412-1416.
19. Züchner S, Mersiyanova IV, Muglia M, Bissar- Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, Jonghe PD, Takahashi Y, Tsuji S, Pericak-Vance MA, Quattrone A, Battaloglu E, Polyakov AV, Timmerman V, Schröder JM, Vance JM: Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36: 449-451.
20. England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF Jr, Lauria G, Miller RG, Polydefkis M, Sumner AJ: Practice parameter: evaluation of distal symmetric polyneuropathy - role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72: 177-184.
21. Verhoeven K, Claeys KG, Züchner S, Schröder JM, Weis J, Ceuterick C, Jordanova A, Nelis E, de Vriendt E, van Hul M, Seeman P, Mazanec R, Saifi GM, Szigeti K, Mancias P, Butler IJ, Kochanski A, Ryniewicz B, de Bleecker J, van den Bergh P, Verellen C, van Coster R, Goemans N, Auer-Grumbach M, Robberecht W, Milic Rasic V, Nevo Y, Tournev I, Guergueltcheva V, Roelens F, Vieregge P, Vinci P, Moreno MT, Christen HJ, Shy ME, Lupski JR, Vance JM, de Jonghe P, Timmerman V: MFN2 mutation distribution and genotype/ phenotype correlation in Charcot-Marie- Tooth type 2. Brain 2006; 129: 2093-2102.
22. Mostacciuolo ML, Micaglio G, Fardin P, Danieli GA: Genetic epidemiology of hereditary motor sensory neuropathies (type I). Am J Med Genet 1991; 39: 479-481.
23. Mostacciuolo ML, Schiavon F, Angelini C, Miccoli B, Piccolo F, Danieli GA: Frequency of duplication at 17p11.2 in families of northeast Italy with Charcot-Marie-Tooth disease type 1. Neuroepidemiology 1995; 14: 49-53.
24. MacMillan JC, Harper PS: The Charcot-Marie- Tooth syndrome: clinical aspects from a population study in South Wales, UK. Clin Genet 1994; 45: 128-134.
25. Holmberg BH: Charcot-Marie-Tooth disease in northern Sweden: an epidemiological and clinical study. Acta Neurol Scand 1993; 87: 416-422.
26. Werdelin L, Keiding N: Hereditary ataxias: epidemiological aspects. Neuroepidemiology 1990; 9: 321-331.
27. Radhakrishnan K, Maloo JC, Poddar SK, Mousa ME: Central nervous system infections in Benghazi, Libya: experience from a community-based adult medical neurology set-up. J Trop Med Hyg 1987; 90: 123-126.
28. Combarros O, Calleja J, Polo JM, Berciano J: Prevalence of hereditary motor and sensory neuropathy in Cantabria. Acta Neurol Scand 1987; 75: 9-12.
29. Skre H: Genetic and clinical aspects of Charcot- Marie-Tooth's disease. Clin Genet 1974; 6: 98-118.
30. Aiyesimoju AB, Osuntokun BO, Bademosi O, Adeuja AO: Hereditary neurodegenerative disorders in Nigerian Africans. Neurology 1984; 34: 361-362.
31. Kurtzke JF, Kurland LT, Goldberg ID: The numerical impact of the major neurologic and sense organ disorders. Trans Am Neurol Assoc 1971; 96: 265-267.
32. Dubourg O, Azzedine H, Verny C, Durosier G, Birouk N, Gouider R, Salih M, Bouhouche A, Thiam A, Grid D, Mayer M, Ruberg M, Tazir M, Brice A, LeGuern E: Autosomal-recessive forms of demyelinating Charcot-Marie- Tooth disease. Neuromolecular Med 2006; 8: 75-86.
33. Nelis E, van Broeckhoven C, de Jonghe P, Löfgren A, Vandenberghe A, Latour P, le Guern E, Brice A, Mostacciuolo ML, Schiavon F, Palau F, Bort S, Upadhyaya M, Rocchi M, Archidiacono N, Mandich P, Bellone E, Silander K, Savontaus ML, Navon R, Goldberg- Stern H, Estivill X, Volpini V, Friedl W, Gal A, et al: Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 1996; 4: 25-33.
34. Mersiyanova IV, Ismailov SM, Polyakov AV, Dadali EL, Fedotov VP, Nelis E, Löfgren A, Timmerman V, van Broeckhoven C, Evgrafov OV: Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie- Tooth neuropathy patients. Hum Mutat 2000; 15: 340-347.
35. Laura M, Milani M, Morbin M, Moggio M, Ripolone M, Jann S, Scaioli V, Taroni F, Pareyson D: Rapid progression of late-onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain. J Neurol Neurosurg Psychiatry 2007; 78: 1263-1266.
36. Shy ME, Jani A, Krajewski K, Grandis M, Lewis RA, Li J, Shy RR, Balsamo J, Lilien J, Garbern JY, Kamholz J: Phenotypic clustering in MPZ mutations. Brain 2004; 127: 371-384.
37. Kochanski A: Molecular genetics studies in Polish Charcot-Marie-Tooth families. Folia Neuropathol 2005; 43: 65-73.